AlphaYouNP
Insider selling
Naimish Patel sold $211K of CRISPR Therapeutics AG (CRSP) stock
Naimish Patel, Chief Medical Officer of CRISPR Therapeutics AG (CRSP), sold 3,786 shares of CRSP stock worth $211K, per an SEC Form 4 filed Jun 1, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on May 28, 2026, 4 days before it was made public.
CRSP has moved +3.5% since the trade date, from $56.38 to $58.33 (Sep 21, 2026 close).
- Traded
- May 28, 2026
- Disclosed
- Jun 1, 2026
- Filing delay
- 4 days
- Price since
- +3.5%
- Role
- Chief Medical Officer
- Source
- SEC Form 4
More CRSP insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.